[Tissue factor pathway inhibitor (TFPI) and its role in pathology]

REVIEW ARTICLE

[Tissue factor pathway inhibitor (TFPI) and its role in pathology]

M Rucińska 1 , M Gacko Z Skrzydlewski

1. Zakład Onkologii Akademii Medycznej w Białymstoku.

Published:

GICID: 01.3001.0000.3142

Available language versions: en pl

Issue: Postepy Hig Med Dosw 1997; 51 (4)

Abstract

Tissue factor pathway inhibitor (TFPI) is an important regulator of blood coagulation. It was described as antyconwertin (AC), extrinsic pathway inhibitor (EPI) and lipoprotein-associated coagulation inhibitor (LACI). TFPI is a glycoprotein, which is mainly synthesized by vascular endothelial cells. The concentration of this enzyme in plasma is low (100 ng/ml). TFPI inhibits activity of factor Xa and complex FVIIa/TF. Changes TFPI activity play an important role in coagulation disorders and presently the function of TFPI in various kinds of diseases is discussed.

Skip to content